The Tungsten+PLUS™ platform delivers comprehensive downstream services, including MFP claims reconciliation, dispute ...

HHS is scrapping its proposed 340B rebate pilot after hospitals sued to stop it. Providers say the plan would have created cash flow problems and administrative burdens that threatened safety-net care ...

Only a week after calling it quits on a court-halted pilot program, the Trump administration is already revving the engine on how it could test out a rebate model for the 340B Drug Discount program | ...

Unchecked abuse of the 340B program shifts costs onto Virginia patients and businesses, the Global Coalition on Aging’s ...

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...

The Trump administration agreed to drop a controversial pilot that would have allowed drugmakers to give post-sales rebates ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

The drug industry and hospitals have been butting heads over the future of a federal drug pricing program for more than a year, according to The Washington Post. Federal regulators may finalize ...

The federal government could be getting more help in defending its interpretation of a decades-old drug discount program in court. On Thursday, a group of hospitals filed a motion to intervene as ...

Congress needs to act to bring needed reforms into the 340B to make revenue from the drug pricing program more transparent and to ensure patients are benefiting from the discounts, according to a ...